Tanai Therapeutics
Latest round
- Seed
Last raised
- Sep 2024
Total raised
- $3.1M
Investors
- 5
About Tanai Therapeutics
Based in Belgium, Tanai Therapeutics is a company developing a first-in-class, oral obesity drug. Tanai Therapeutics is a biotechnology company focused on developing a novel oral therapeutic for obesity. The company's approach targets a genetically validated pathway involved in energy expenditure, aiming to promote fat loss while preserving muscle mass. The company’s research is based on work conducted at the VIB-UGent Center for Inflammation Research, and it is advancing toward in-vivo proof-of-concept.
Who invested in Tanai Therapeutics
5 investors across 2 rounds
See all investors in Tanai Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tanai Therapeutics
Who invested in Tanai Therapeutics?
Tanai Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tanai Therapeutics raised?
Tanai Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tanai Therapeutics last raise money?
Tanai Therapeutics's most recent round on record is a Seed, in Sep 2024.
What does Tanai Therapeutics do?
Based in Belgium, Tanai Therapeutics is a company developing a first-in-class, oral obesity drug.
Where is Tanai Therapeutics headquartered?
Tanai Therapeutics is headquartered in Belgium.
Which VCs invest in companies like Tanai Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back pharmaceuticals companies at Tanai Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Tanai Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.